Ra Pharmaceuticals, Inc. Contracts & Agreements

Second Amendment to Lease Agreement, dated March 11, 2020, by and between Ra Pharmaceuticals, Inc. and HCP/King 87 CPD LLC (Filed With SEC on March 16, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

License Agreement, dated as of July 15, 2019, by and between the Registrant and Camurus AB (Filed With SEC on November 7, 2019)

Agreement and Plan of Merger, dated October 9, 2019, by and among UCB S.A., Franq Merger Sub, Inc. and Ra Pharmaceuticals, Inc (Filed With SEC on October 10, 2019)

Non-Employee Director Compensation Policy, effective April 1, 2019 (Filed With SEC on August 7, 2019)

Underwriting Agreement, dated July 23, 2019, between the Company and Jefferies LLC, BMO Capital Markets Corp. and Stifel, Nicolaus & Company, Incorporated, as representatives of... (Filed With SEC on July 26, 2019)

Open Market Sale AgreementSM, dated as of May 9, 2019, by and between Ra Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on May 9, 2019)

Underwriting Agreement, dated December 11, 2018, between the Company and Jefferies LLC, BMO Capital Markets Corp. and Stifel, Nicolaus & Company, Incorporated, as representatives... (Filed With SEC on December 14, 2018)

Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2018)

Sales Agreement, dated as of May 9, 2018, by and between Ra Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on May 9, 2018)

Underwriting Agreement, dated February 14, 2018, between the Company and Credit Suisse Securities (USA) LLC, Jefferies LLC and BMO Capital Markets Corp., as representatives of the... (Filed With SEC on February 16, 2018)

RA PHARMACEUTICALS, INC. 2016 STOCK AWARD AND INCENTIVE PLAN (Filed With SEC on October 13, 2016)

RA PHARMACEUTICALS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on October 13, 2016)

RA PHARMACEUTICALS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 13, 2016)

RA PHARMACEUTICALS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on October 13, 2016)

[ *** ] TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2... (Filed With SEC on October 13, 2016)

EXCLUSIVE LICENSE AGREEMENT by and between Anthony C. Forster, M.D., Ph.D. an individual and Ra Pharmaceuticals, Inc. a Delaware corporation (Filed With SEC on October 13, 2016)

Research and Development Collaboration and License agreement (Filed With SEC on October 13, 2016)

RA PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 30, 2016)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 30, 2016)

RA PHARMACEUTICALS, INC. COMMON STOCK WARRANT Original Issue Date: December 1, 2010 Void After: 5 PM Boston Time on December 1, 2020 This Warrant Is Issued to Stephen C. Blacklow (Filed With SEC on September 30, 2016)

RA PHARMACEUTICALS, INC. 2010 STOCK OPTION AND GRANT PLAN (Filed With SEC on September 30, 2016)

[ *** ] TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2... (Filed With SEC on September 30, 2016)